Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Asset Utilization Ratio (2017 - 2023)

Acro Biomedical has reported Asset Utilization Ratio over the past 7 years, most recently at 1.29 for Q3 2023.

  • Quarterly results put Asset Utilization Ratio at 1.29 for Q3 2023, down 5.54% from a year ago — trailing twelve months through Sep 2023 was 1.29 (down 5.54% YoY), and the annual figure for FY2022 was 0.91, down 33.22%.
  • Asset Utilization Ratio for Q3 2023 was 1.29 at Acro Biomedical, up from 0.6 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for ACBM hit a ceiling of 4.94 in Q1 2019 and a floor of 0.1 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.9 (2020), compared with a mean of 1.29.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 96.65% in 2019 and later soared 1724.91% in 2022.
  • Acro Biomedical's Asset Utilization Ratio stood at 0.19 in 2019, then soared by 259.59% to 0.69 in 2020, then surged by 148.68% to 1.72 in 2021, then plummeted by 42.54% to 0.99 in 2022, then soared by 30.38% to 1.29 in 2023.
  • The last three reported values for Asset Utilization Ratio were 1.29 (Q3 2023), 0.6 (Q2 2023), and 0.54 (Q1 2023) per Business Quant data.